Personal information

Other IDs

Scopus Author ID: 58972375500

Activities

Collapse all

Employment (1)

University of Szeged: Szeged, HU

2021-08-01 to present | Resident physician / PhD Student (Department of Internal Medicine)
Employment
Source: Self-asserted source
Bernadett Farkas

Education and qualifications (1)

University of Szeged: Szeged, HU

2015-09-01 to 2021-07-02 | Medical degree
Education
Source: Self-asserted source
Bernadett Farkas

Professional activities (2)

Hungarian Society of Gastroenterology: Budapest, HU

Membership
Source: Self-asserted source
Bernadett Farkas

European Crohn's and Colitis Organisation: Vienna, AT

Y-ECCO
Membership
Source: Self-asserted source
Bernadett Farkas

Works (17)

Diagnostic and Therapeutic Challenges in Severe Peristomal Pyoderma Gangrenosum

Inflammatory Bowel Diseases
2025-03-03 | Journal article
DOI: 10.1093/ibd/izae167
Contributors: Bernadett Farkas; Emese Ivány; Anita Bálint; Peter Bacsur; Tamás Molnár; Klaudia Farkas
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study

Alimentary Pharmacology & Therapeutics
2025-01 | Journal article
DOI: 10.1111/apt.18359
Contributors: Péter Bacsur; Daniel Shaham; Zuzana Serclova; Tamás Resál; Bernadett Farkas; Patrícia Sarlós; Pál Miheller; Nitsan Maharshak; Meir Zemel; Ariella Bar‐Gil Shitrit et al.
Source: check_circle
Crossref

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system

Therapeutic Advances in Gastroenterology
2024 | Journal article
DOI: 10.1177/17562848241239606
EID:

2-s2.0-85189535938

Part of ISSN: 17562848 1756283X
Contributors: Bacsur, P.; Wetwittayakhlang, P.; Resál, T.; Földi, E.; Vasas, B.; Farkas, B.; Rutka, M.; Bessissow, T.; Afif, W.; Bálint, A. et al.
Source: Self-asserted source
Bernadett Farkas via Scopus - Elsevier

Efficacy, drug sustainability, and safety of ustekinumab treatment in Crohn’s disease patients over three years

Research Square
2024 | Other
DOI: 10.21203/rs.3.rs-3952188/v1
EID:

2-s2.0-85189870821
Contributors: Barkai, L.J.; Gonczi, L.; Balogh, F.; Angyal, D.; Farkas, K.; Farkas, B.; Molnar, T.; Szamosi, T.; Schafer, E.; Golovics, P.A. et al.
Source: Self-asserted source
Bernadett Farkas via Scopus - Elsevier

Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study

Inflammatory Bowel Diseases
2024 | Journal article
DOI: 10.1093/ibd/izad135
EID:

2-s2.0-85179476874

Part of ISSN: 15364844 10780998
Contributors: Resál, T.; Bacsur, P.; Keresztes, C.; Bálint, A.; Bor, R.; Fábián, A.; Farkas, B.; Katsanos, K.; Michalopoylos, G.; Ribaldone, D.G. et al.
Source: Self-asserted source
Bernadett Farkas via Scopus - Elsevier

Real-World Effectiveness and Safety of Selective JAK Inhibitors in Ulcerative Colitis and Crohn’s Disease: A Retrospective, Multicentre Study

Journal of Clinical Medicine
2024-12-20 | Journal article
DOI: 10.3390/jcm13247804
Contributors: Bernadett Farkas; Talat Bessissow; Jimmy K. Limdi; Karishma Sethi-Arora; Anna Kagramanova; Oleg Knyazev; Cristina Bezzio; Alessandro Armuzzi; Milan Lukas; George Michalopoulos et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Shotgun Analysis of Gut Microbiota with Body Composition and Lipid Characteristics in Crohn’s Disease

Biomedicines
2024-09-14 | Journal article
DOI: 10.3390/biomedicines12092100
Contributors: Péter Bacsur; Tamás Resál; Bernadett Farkas; Boldizsár Jójárt; Zoltán Gyuris; Gábor Jaksa; Lajos Pintér; Bertalan Takács; Sára Pál; Attila Gácser et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Terápiás kihívások nehezen kezelhető, penetráló Crohn-betegségben – multidiszciplináris megoldás

Orvosi Hetilap
2024-08-11 | Journal article
DOI: 10.1556/650.2024.33105
Part of ISSN: 0030-6002
Part of ISSN: 1788-6120
Contributors: Bernadett Farkas; Péter Bacsur; Emese Ivány; Anita Bálint; Mariann Rutka; Klaudia Farkas; Tamás Molnár
Source: Self-asserted source
Bernadett Farkas

Long-term outcomes after endoscopic removal of malignant colorectal polyps: Results from a 10-year cohort

World Journal of Gastrointestinal Endoscopy
2024-04-16 | Journal article
DOI: 10.4253/wjge.v16.i4.193
Part of ISSN: 1948-5190
Contributors: Anna Fábián; Renáta Bor; Béla Vasas; Mónika Szűcs; Tibor Tóth; Zsófia Bősze; Kata Judit Szántó; Péter Bacsur; Anita Bálint; Bernadett Farkas et al.
Source: Self-asserted source
Bernadett Farkas

Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases

Therapeutic Advances in Gastroenterology
2024-01 | Journal article
DOI: 10.1177/17562848241290636
Contributors: Péter Bacsur; Tamás Resál; Patrícia Sarlós; Ákos Iliás; Liza Dalma Sümegi; Diána Kata; Anett Dávid; Bernadett Farkas; Emese Ivány; Anita Bálint et al.
Source: check_circle
Crossref

P1016 Real-world data on sequential therapy in moderate-to-severe UC: Unveiling second-line strategies after anti-TNF failure

Journal of Crohn's and Colitis
2024-01-24 | Journal article
DOI: 10.1093/ecco-jcc/jjad212.1146
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: B Farkas; M Borsos; T Resál; P Bacsur; Z Szepes; E V Savarino; L Bertin; J K Limdi; K Sethi-Arora; P Miheller et al.
Source: Self-asserted source
Bernadett Farkas

P356 Long-term outcome of UC patients in clinical remission with different level of mucosal activity: real world, retrospective, multicontinental study

Journal of Crohn's and Colitis
2024-01-24 | Journal article
DOI: 10.1093/ecco-jcc/jjad212.0486
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: P Bacsur; P Wetwittayakhlang; T Resál; B Farkas; M Rutka; T Bessissow; W Afif; A Bálint; A Fábián; R Bor et al.
Source: Self-asserted source
Bernadett Farkas

P560 The impact of reactive point-of-care drug level measurement on the medium-term course of inflammatory bowel disease

Journal of Crohn's and Colitis
2024-01-24 | Journal article
DOI: 10.1093/ecco-jcc/jjad212.0690
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: E Ivány; B Farkas; T Resál; P Bacsur; A Bálint; K Farkas; T Molnár
Source: Self-asserted source
Bernadett Farkas
grade
Preferred source (of 2)‎

P661 Ustekinumab in Crohn’s disease: A three-year multicentre prospective study from Hungary - Assessing efficacy, drug sustainability, and safety

Journal of Crohn's and Colitis
2024-01-24 | Journal article
DOI: 10.1093/ecco-jcc/jjad212.0791
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: L J Barkai; L Gonczi; K Farkas; B Farkas; T Molnar; T Szamosi; E Schafer; P Golovics; M Juhasz; A Patai et al.
Source: Self-asserted source
Bernadett Farkas

P674 Real-world experiences of switching to subcutaneous formulation in IBD patients on maintenance vedolizumab treatment

Journal of Crohn's and Colitis
2024-01-24 | Journal article
DOI: 10.1093/ecco-jcc/jjad212.0804
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: P Bacsur; T Resál; B Farkas; P Sarlós; Á Iliás; D Kata; A Bálint; A Fábián; R Bor; Z Szepes et al.
Source: Self-asserted source
Bernadett Farkas

Az immunszuppresszív és biológiai terápia időzítése gyulladásos bélbetegségben

Central European Journal of Gastroenterology and Hepatology
2023 | Journal article
DOI: 10.33570/ceujgh.9.2.63
Part of ISSN: 2415-9107
Contributors: Bernadett Farkas; Tamás Molnár; Klaudia Farkas
Source: Self-asserted source
Bernadett Farkas

P739 Sequential treatment is effective to achieve remission and avoid colectomy in moderate-to-severe Ulcerative Colitis refractory to anti-TNF therapy

Journal of Crohn's and Colitis
2023-01-30 | Journal article
DOI: 10.1093/ecco-jcc/jjac190.0869
Part of ISSN: 1873-9946
Part of ISSN: 1876-4479
Contributors: B Farkas; M Borsos; T Resál; P Bacsur; R Bor; A Bálint; A Fábián; Z Szepes; T Molnár; K Farkas
Source: Self-asserted source
Bernadett Farkas
How many people are using ORCID?